More importantly, Trp53−/− mice obtained maximal tumor scores of (2), whereas Trp53+/− showed 0.6 and Trp53+/+ 0.8 in colonoscopy imaging, showing that only Trp53−/− showed multiple tumors in the ninth week of AOM/DSS administration (Figure S2B). This evidence concerns the gene TP53 and neoplasm.